IMS Health (RX) Near Deal To Sell Itself In $4B LBO - WSJ
More News related to RX
- BioSyent Releases 2009 Third Quarter Financial Results
- BioSyent Releases 2009 Third Quarter Financial Results
- Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low
- IMS Health to Launch Oncology Quantifier, Delivering Integrated Insights for Enhanced Market Measurement, Commercial Strategies
- Law Offices of Brian M. Felgoise, P.C. Announces Investigation on Behalf of Shareholders of IMS Health, Inc.
According to reports from the Wall Street Journal, IMS Health Inc. (NYSE: RX) is nearing a deal to sell itself to private-equity firm TPG and the Canada Pension Plan in a deal that could have a value of almost $4 billion.
Share are up 14% this AM.
Related Categories
Hot ListMergers and Acquisitions
Rumors
Stocks Mentioned
-0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
